duplimumab

1. Drug Classification & Indications Dupixent (dupilumab) is a monoclonal antibody that selectively inhibits the interleukin-4 receptor alpha (IL-4Rα), thereby blocking signaling of both IL-4 and IL-13, two key cytokines implicated in type 2 inflammation. Indications: 2. Mechanism of Action 3. Dosing & Administration Adults and Children: Special Considerations: 4. Pharmacovigilance & Safety Monitoring Common…